Cargando…
The immune‐related role of BRAF in melanoma
BACKGROUND: The existence of a dichotomy between immunologically active and quiescent tumor phenotypes has been recently recognized in several types of cancer. The activation of a Th1 type of immune signature has been shown to confer better prognosis and likelihood to respond to immunotherapy. Howev...
Autores principales: | Tomei, Sara, Bedognetti, Davide, De Giorgi, Valeria, Sommariva, Michele, Civini, Sara, Reinboth, Jennifer, Al Hashmi, Muna, Ascierto, Maria Libera, Liu, Qiuzhen, Ayotte, Ben D., Worschech, Andrea, Uccellini, Lorenzo, Ascierto, Paolo A., Stroncek, David, Palmieri, Giuseppe, Chouchane, Lotfi, Wang, Ena, Marincola, Francesco M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500792/ https://www.ncbi.nlm.nih.gov/pubmed/25174651 http://dx.doi.org/10.1016/j.molonc.2014.07.014 |
Ejemplares similares
-
The immune-related role of BRAF in melanoma
por: Tomei, Sara, et al.
Publicado: (2015) -
The stable traits of melanoma genetics: an alternate approach to target discovery
por: Spivey, Tara L, et al.
Publicado: (2012) -
IRF-1 responsiveness to immune cytokines predicts different cancer phenotypes
por: Murtas, Daniela, et al.
Publicado: (2013) -
An immunologic portrait of cancer
por: Ascierto, Maria Libera, et al.
Publicado: (2011) -
Association between HRAS rs12628 and rs112587690 polymorphisms with the risk of melanoma in the North American population
por: Tomei, Sara, et al.
Publicado: (2012)